Extrapolating evidence beyond age groups

J Allergy Clin Immunol. 2008 Apr;121(4):1066-7; author reply 1067-8. doi: 10.1016/j.jaci.2008.01.068. Epub 2008 Mar 5.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Comment

MeSH terms

  • Acetates / administration & dosage
  • Acetates / adverse effects
  • Acetates / therapeutic use
  • Administration, Inhalation
  • Administration, Oral
  • Age Factors
  • Anti-Asthmatic Agents* / administration & dosage
  • Anti-Asthmatic Agents* / adverse effects
  • Anti-Asthmatic Agents* / therapeutic use
  • Asthma / drug therapy*
  • Budesonide / administration & dosage
  • Budesonide / adverse effects
  • Budesonide / therapeutic use
  • Child
  • Child, Preschool
  • Cyclopropanes
  • Female
  • Humans
  • Infant
  • Leukotriene Antagonists / administration & dosage
  • Leukotriene Antagonists / adverse effects
  • Leukotriene Antagonists / therapeutic use
  • Male
  • Quinolines / administration & dosage
  • Quinolines / adverse effects
  • Quinolines / therapeutic use
  • Randomized Controlled Trials as Topic / standards
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Research Design / standards*
  • Research Design / statistics & numerical data*
  • Sulfides
  • Treatment Outcome

Substances

  • Acetates
  • Anti-Asthmatic Agents
  • Cyclopropanes
  • Leukotriene Antagonists
  • Quinolines
  • Sulfides
  • Budesonide
  • montelukast